Mitochondria modulate Tau pathology and neuroinflammation

线粒体调节 Tau 病理学和神经炎症

基本信息

批准号：
10404618
负责人：
Shirley ShiDu Yan
金额：
$ 59.59万
依托单位：
COLUMBIA UNIVERSITY HEALTH SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-09-15 至 2025-05-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10404618
关键词：
Address Affect Age Alzheimer&apos s Disease Alzheimer&apos s disease brain Alzheimer&apos s disease pathology Alzheimer&apos s disease patient Alzheimer&apos s disease therapeutic Amyloid beta-Protein Attenuated Behavioral Blood Platelets Brain Cell Death Cell Line Cell Membrane Permeability Cerebrum Cognitive Data Defect Disease Progression Environment Functional disorder Genetic Goals Human Hybrids Immune Impaired cognition In Vitro Inflammation Inflammatory Injury Lead Learning Link MAPT gene Maintenance Mediating Mediator of activation protein Memory Memory impairment Metabolism Microglia Mitochondria Mitochondrial DNA Mitochondrial Diseases Modeling Molecular Mus Natural Immunity Nerve Degeneration Neurons Outcome Outcome Study Pathogenesis Pathologic Pathology Patients Pattern Pattern recognition receptor Peptidylprolyl Isomerase Phagocytosis Play Production Property Research Role Signal Transduction Stress Synapses Synaptic Transmission Synaptosomes TLR9 gene Tauopathies Testing Therapeutic Agents Toxic effect Transcriptional Activation chemokine cognitive function cyclophilin D cytokine feasibility research genetic manipulation human model hyperphosphorylated tau in vivo insight mitochondrial dysfunction mitochondrial membrane mitochondrial permeability transition pore mouse model neurofibrillary tangle formation neuroinflammation neuron loss new therapeutic target novel novel therapeutics protective effect receptor for advanced glycation endproducts response synaptic function synaptic pruning tau Proteins tau aggregation tau mutation tau-1 transcription factor

项目摘要

Project Summary Mitochondrial dysfunction and synaptic damage are early pathological features of the Alzheimer's disease (AD)- affected brain. Microtubule associated protein tau (MAPT) plays a major role in AD and have deleterious effects on mitochondrial and synaptic function. Accumulation of abnormal Tau, including Tau oligomers, causes mitochondrial and synaptic damage, inflammation, and memory impairment. The underlying mechanisms of abnormal Tau accumulation and strategies to eliminate them to restore mitochondrial function remain largely unknown. Cyclophilin D (CypD) is an integral part in the formation of the mitochondrial permeability transition pore (mPTP), leading to cell death. Loss of CypD protects against Aβ-induced mitochondrial and synaptic injury. However, the role of CypD in tau-mediated mitochondrial and Tau pathology has not been explored. In our preliminary studies, we found that CypD specifically interacts with tau in AD brains and Tauopathy model. Loss of CypD robustly reduced hyperphosphorylated Tau and Tau oligomers and restored mitochondrial and cognitive function in human mutant Tau mice. Furthermore, CypD-deficient Tau mice revealed suppression of induction of proinflammatory mediators. These exciting results lead us to hypothesize that CypD-mediated mitochondrial dysfunction provokes neuroinflammation, contributing to abnormal tau metabolism and clearance. To test this hypothesis, we will investigate whether blockade of CypD promotes abnormal tau clearance consequently reducing tauopathy and thereby alleviating tau-induced aberrant mitochondrial and cognitive decline in AD. Utilizing novel genetically manipulated CypD-AD mouse models and neuronal culture with altered CypD levels in tau-rich environment, and AD cybrids containing patient AD-derived mitochondria, we will elucidate CypD- dependent mechanisms underlying Tau pathology, clearance, mitochondrial alterations, and neuroinflammation.

项目摘要线粒体功能障碍和突触损伤是阿尔茨海默氏病（AD）的早期病理特征 - 受影响的大脑。微管相关蛋白tau（MAPT）在AD中起主要作用，并且已删除了效果在线粒体和突触功能上。包括tau低聚物在内的异常tau的积累会导致线粒体和突触损伤，感染和记忆力障碍。的基本机制 tau的异常积累和消除它们恢复线粒体功能的策略仍然很大未知。环磷脂D（CYPD）是形成线粒体通透性过渡的组成部分孔（MPTP），导致细胞死亡。 CYPD的丧失可预防Aβ诱导的线粒体和突触损伤。但是，尚未探索CYPD在Tau介导的线粒体和TAU病理学中的作用。在我们的初步研究，我们发现CYPD在Ad Brains和Tauopathy模型中特异性与TAU相互作用。损失 CYPD可稳健地降低热磷酸化的tau和tau低聚物，并恢复线粒体和认知在人突变的tau小鼠中的功能。此外，CYPD缺乏的Tau小鼠揭示了诱导的抑制促进介体。这些令人兴奋的结果使我们假设CYPD介导的线粒体功能障碍会引起神经炎症，导致异常的TAU代谢和清除率。测试这个假设，我们将研究CYPD的阻塞是否促进异常TAU清除率减少tauopathy，从而减轻Tau引起的AD的异常线粒体和认知能力下降。利用新型的遗传操纵CYPD-AD小鼠模型和CYPD水平改变的神经元培养在富含tau的环境和含有患者广告衍生的线粒体的AD圆柱体中，我们将阐明CYPD- tau病理学，清除，线粒体改变和神经炎症的依赖机制。